When the expression of NF-κB inhibitor protein α (IκBα) increased, the Bax/Bcl-2 ratio rises, the NF-κB signaling pathway is inhibited, and the process of liver fibrosis is slowed down. The gene discussed is NFKB1; the disease is Hepatic fibrosis.